Australia markets open in 7 hours 27 minutes

Aroa Biosurgery Limited (ARX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
1.1500-0.0350 (-2.95%)
At close: 4:10PM AEST

Aroa Biosurgery Limited

2 Kingsford Smith Place
Airport Oaks Auckland Airport PO Box 107111
Auckland 2150
New Zealand
64 9 869 3035
http://aroabio.com

Sector(s):Β Healthcare
Industry:Β Medical Devices
Full-time employees:Β 

Key executives

NameTitlePayExercisedYear born
Dr. Brian WardFounder, CEO, MD & Exec. DirectorN/AN/AN/A
Mr. James AgnewCFO & Company Sec.N/AN/AN/A
Ms. Simone Von FircksVP of OperationsN/AN/AN/A
Dr. Barnaby C.H. MayVP of TechnologyN/AN/AN/A
Ms. Tracy Weimar BA, MBACompany Sec.N/AN/AN/A
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Aroa Biosurgery Limited, a regenerative medicine company, develops and manufactures medical devices for wound and tissue repair in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobia for treating acute and chronic wounds; Myriad, an implant and dermal procedures for soft tissue repair, reinforcement, and complex wounds; and Reinforced Bioscaffolds, a biologics and synthetics product used in surgical ventral hernia repair solutions. The company was founded in 2008 and is based in Auckland, New Zealand.

Corporate governance

Aroa Biosurgery Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.